Jun 11, 2026 04:39PM
Jun 11, 2026 04:39PM
Feb 26, 2026 06:40PM
Feb 26, 2026 05:55PM
Jan 7, 2026 08:02AM
Dec 31, 2025 03:30PM
Dec 31, 2025 08:42AM Jefferies: 'We see this as a positive for XERS'
Aug 27, 2025 08:35AM
Aug 25, 2025 07:00AM
Aug 25, 2025 07:00AM
May 8, 2025 07:00AM
Mar 17, 2025 08:03AM
Mar 17, 2025 08:00AM
Feb 24, 2025 08:01AM Xeris Pharmaceuticals Inc. (XERS) Appoints Anh Nguyen as Chief Medical Officer
Feb 24, 2025 08:00AM
Nov 11, 2024 07:25AM
Aug 8, 2024 07:00AM
Jun 3, 2024 07:00AM
May 30, 2024 07:30AM
May 30, 2024 07:30AM
Jan 10, 2024 09:02AM Xeris Pharmaceuticals Inc. (XERS) Enters Into an Exclusive Worldwide License Agreement for Xeriject Formulation of Teprotumumab
Jan 10, 2024 08:00AM
Nov 9, 2023 07:00AM
Aug 8, 2023 07:00AM
Jul 31, 2023 07:04AM
Jul 31, 2023 07:00AM
Mar 30, 2023 07:04AM
Mar 30, 2023 07:00AM Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™
Mar 8, 2023 06:00AM
Feb 2, 2023 07:00AM
Jan 30, 2023 07:03AM
Jan 30, 2023 07:00AM
Jan 5, 2023 04:03PM
Jan 5, 2023 07:04AM
Jan 5, 2023 07:00AM Xeris Biopharma Updates Its Outlook For 2022
Dec 15, 2022 07:05AM
Dec 15, 2022 07:00AM
Nov 23, 2022 06:03AM
Nov 23, 2022 06:00AM
Nov 9, 2022 07:00AM
Nov 2, 2022 07:00AM
Nov 1, 2022 07:00AM Xeris Biopharma Announces Results of the Extended Evaluation of Recorlev® (Levoketoconazole) From the Phase 3 Sonics Study Published in the European Journal of Endocrinology
Oct 20, 2022 06:40AM
Oct 20, 2022 06:00AM
Aug 10, 2022 07:00AM
Aug 3, 2022 07:30AM
Aug 1, 2022 07:30AM
Aug 1, 2022 07:30AM
May 12, 2022 04:02PM Xeris Announces Full Results From the Logics Study of Recorlev® and Presentation of New Burden of Illness in Cushing’s Syndrome Data at AACE Annual Meeting May 12-14
May 11, 2022 07:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All